Search results
U.S. Capital Wealth Advisors LLC Sells 2,619 Shares of Vanguard Intermediate-Term Bond ETF...
ETF DAILY NEWS· 22 hours agoU.S. Capital Wealth Advisors LLC lessened its stake in Vanguard Intermediate-Term Bond ETF (NYSEARCA:BIV – Free Report) by 49.5% in the fourth quarter, ...
A Century-Old Company The Government Owns Wants To Solve A Big Energy Problem
HuffPost via Yahoo Finance· 6 days agoS. population. Faced with soaring debt from unfinished projects that would never earn money,...
Here’s How Much the Average American Spends on Gas in a Lifetime in Every State
GoBankingRates via AOL· 18 hours agoThe price of gasoline in the U.S. is shaped by a variety of factors, including the cost of crude...
Catalyst (CPRX) Q1 Earnings Beat, Firdapse Sales Drive Revenues
Zacks via Yahoo Finance· 14 hours agoDuring the same time frame, the estimate for Ligand’s 2025 earnings per share has remained constant...
Earnings call: Esperion reveals robust Q1 growth, FDA approval boosts By Investing.com
Investing.com· 3 days agoEsperion Therapeutics Inc. (NASDAQ:ESPR) has reported a significant surge in its first-quarter...
Investigators seek answers from Ford on fuel leak recall involving 43K SUVs
MLive.com· 16 hours agoAccording to the Associated Press, as part of its investigation into the issue, the NHTSA has asked...
Esperion (ESPR) Q1 Earnings Beat, Stock Up on Strong Revenues
Zacks via Yahoo Finance· 2 days agoEsperion generated revenues of $137.7 million, up nearly 467% year over year. The upside...
Heart Disease Drugmaker Esperion Therapeutics Reports Highest Revenue Yet, Stock Soars
Benzinga via Yahoo Finance· 3 days agoTuesday, Esperion Therapeutics (NASDAQ:ESPR) reported first-quarter revenues of $137.74 million, up...
Esperion Therapeutics Inc (ESPR) Surpasses Q1 Revenue Forecasts with a 467% Increase
GuruFocus.com via Yahoo Finance· 3 days agoThis performance... approvals for label expansions of NEXLETOL and NEXLIZET, enhancing their market potential. U.S. net product revenue grew by 46% year-over-year ...
Canaccord Genuity Group Lowers EZCORP (NASDAQ:EZPW) Price Target to $17.00
ETF DAILY NEWS· 5 days agoEZCORP (NASDAQ:EZPW – Get Free Report) had its target price reduced by equities researchers at Canaccord Genuity Group from $18.00 to $17.00 in a research note issued to investors on Friday, ...